US EditionMedtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
Summary by Helena Independent Record
7 Articles
7 Articles
All
Left
Center
4
Right
Montana Standard+6 Reposted by 6 other sources
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy (RF/PF), focal Sphere-9™ catheter demonstrates efficacy for linear ablation in persistent AFibMedtronic continues legacy of leadership in innovation,…
Coverage Details
Total News Sources7
Leaning Left0Leaning Right0Center4Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage